In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (Q90160332)
Jump to navigation
Jump to search
scientific article published on 09 March 2020
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) |
scientific article published on 09 March 2020 |
Statements
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (English)
Xueting Yao
Fei Ye
Miao Zhang
Cheng Cui
Baoying Huang
Peihua Niu
Xu Liu
Li Zhao
Erdan Dong
Chunli Song
Siyan Zhan
Roujian Lu
Haiyan Li
9 March 2020
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
0 references
Identifiers
1 reference